Respiri Limited announced that Dr. Thomas Duthy has been appointed as a Non-Executive Director of the company, effective February 11, 2020. Tom has over 15 years of direct financial market and medical device industry experience. Tom is the Founder and CEO of Nemean Group Pty Ltd. Prior to establishing Nemean Group, he was Global Head of Investor Relations and Corporate Development at Sirtex Medical Limited, which was sold for $1.9 billion in late 2018. Additionally, he spent 10 years as a leading sector analyst specializing in Healthcare and Biotechnology companies.